Johanna Friedl-Naderer

Chief Commercial Officer, Dyne Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.0M

Companies

Latest trade

Sep 8, 2026

Companies

Dyne Therapeutics, Inc.Chief Commercial Officer −$0.0M

Trades

DYN Sold 185 shares at $18.88 · planned $0.0M Sep 8

DYN Sold 900 shares at $24.35 · planned $0.0M Sep 4

DYN Sold 226 shares at $26.28 · planned $0.0M Aug 13

DYN Sold 145 shares at $18.33 · planned $0.0M Jun 16

DYN Sold 228 shares at $18.36 · planned $0.0M May 13

DYN Sold 148 shares at $14.90 · planned $0.0M Mar 5

DYN Sold 144 shares at $20.72 · planned $0.0M Dec 5

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.